CHESTGuidelines & Topic CollectionsACR/CHEST Clinical Practice Guidelines and Screening of ILD With Systemic Autoimmune Rheumatic Diseases

ACR/CHEST Clinical Practice Guidelines and Screening of ILD With Systemic Autoimmune Rheumatic Diseases

Recorded: June 17, 2025

Interstitial lung disease (ILD) remains a significant cause of morbidity and mortality in patients with systemic autoimmune rheumatic diseases (SARDs). Lack of evidence-based standardization of screening and monitoring for SARD-ILD has resulted in wide variation in clinical practice. Recent jointly published clinical practice guidelines by CHEST and the American College of Rheumatology (ACR) aim to improve detection of SARD-ILD and its progression. In this webinar, a multidisciplinary panel from the CHEST Diffuse Lung Disease and Lung Transplant Network’s ILD Section focused on navigating these guidelines and practically applying them to clinical practice. Gain valuable insight into approaches to evaluating ILD in this high-risk population of patients with SARD. Plus, watch a previous video on treatment guidelines for SARD-ILD.

Watch more from this Section: A Review of ACR/CHEST Clinical Practice Guidelines on Treatment of ILD With Systemic Autoimmune Rheumatic Diseases »


Advertisement



Host

Anthony J. Esposito, MD, FCCP

Assistant Professor of Medicine
Division of Pulmonary and Critical Care
Northwestern University
Chicago, IL


Host

Tejaswini Kulkarni, MD, MBBS, FCCP

Associate Professor of Medicine
Division of Pulmonary, Allergy, and Critical Care Medicine
The University of Alabama at Birmingham
Birmingham, AL


Panelist

Jonathan H. Chung, MD

Professor of Radiology
Division of Cardiothoracic Imaging
University of California San Diego
San Diego, CA


Panelist

Dinesh Khanna, MD, MSc

Professor of Medicine
Frederick G. L. Huetwell Professor of Rheumatology
Director, University of Michigan Scleroderma Program
Division of Rheumatology/Department of Internal Medicine
Medical Director, M-Clinical Trials Support Unit (M-CTSU) and Michigan Clinical Research Unit (MCRU)
Ann Arbor, MI


Panelist

Mary Strek, MD, FCCP

Professor of Medicine
Section of Pulmonary and Critical Care Medicine
The University of Chicago
Chicago, IL


Advertisement